Novartis AG (NVSEF) Gross profit 2016–2025
Novartis AG (NVSEF) annual gross profit history from SEC filings — each fiscal year as reported.
$43.0BFY2025 · since FY2016: $31.9B → $43.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $43.0B | +10.5% |
| FY2024 | $38.9B | +13.8% |
| FY2023 | $34.2B | +7.2% |
| FY2022 | $31.9B | -1.1% |
| FY2021 | $32.2B | -7.3% |
| FY2020 | $34.8B | +1.5% |
| FY2019 | $34.3B | +8.4% |
| FY2018 | $31.6B | +6.1% |
| FY2017 | $29.8B | -6.7% |
| FY2016 | $31.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice